Represented a consortium comprised of China Resources, one of China’s largest state-owned enterprises, and Macquarie Capital, on its acquisition of the majority interest in GenesisCare Limited and associated shareholders’ agreement and management incentive plan. Corrs also advised Macquarie Capital on its subsequent exit from GenesisCare and sale of its interests to funds advised by KKR. GenesisCare is Australia's largest provider of radiation oncology, cardiology and sleep treatments with operations in the United Kingdom and Spain.
This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.